Table 1 Correlation between HK2 expression and clinicopathologic characteristics of glioma patients
From: The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma
Characteristics | Cases | HK2 low expression | HK2 high expression | P-value |
|---|---|---|---|---|
Age (year) | ||||
  ≥ 60 | 15 | 8 (53.3%) | 7 (46.7%) | 0.735 |
  < 60 | 66 | 32 (48.5%) | 34 (51.5%) | |
Gender | ||||
 Male | 55 | 27 (49.1%) | 28 (50.9%) | 0.939 |
 Female | 26 | 13 (50%) | 13 (50%) | |
Grades | ||||
 LGG (I + II) | 40 | 37 (92.5%) | 3 (7.5%) | < 0.001 |
 HGG (III + IV) | 41 | 3 (7.3%) | 38 (92.7%) | |
Tumor recurrence | ||||
 Yes | 47 | 15 (36.2%) | 32 (63.8%) | |
 No | 34 | 25 (73.5%) | 9 (26.5%) | < 0.001 |